Rakovina Therapeutics to Participate in BioInnovate UBC Annual Conference

VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, today announced its participation in the BioInnovate UBC Annual Conference on February 1, 2025. This premier event, hosted at the University of British Columbia (UBC), unites academic researchers, biotech innovators, and industry professionals to foster collaboration and showcase ...